Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Suppressors of electron leak (SELs)
- Identification of SELs for site IIIQo (S3QELs) (1)
- Identification of SELs for site IIIQo (S3QELs) (2)
- Identification of SELs for site IQ (S1QELs)
- Recap: excellent suppression of 2 important sites
- Mitochondrial ROS in signaling and disease
- Some biological effects of SELs
- Site IIIQo & S3QELs versus site IQ & S1QELs
- S1QELs & S3QELs and basal ROS production
- S1QELs & S3QELs and redox signaling
- S1QELs & S3QELs and ROS damage
- Summary
- Acknowledgements
Topics Covered
- Suppressors of electron leaks (SELs)
- Identification of SELs for various sites
- Mitochondrial ROS in signaling and disease
- Some biological effects of SELs
- Comparisons between SELs
- SELs as novel tools to diagnose and modify ROS signaling and damage
Links
Series:
Categories:
Talk Citation
Brand, M. (2018, February 28). Mitochondrial production of reactive oxygen species 2 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 13, 2024, from https://doi.org/10.69645/IPFG9808.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Martin Brand has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Mitochondrial production of reactive oxygen species 2
Published on February 28, 2018
22 min
Other Talks in the Series: Mitochondria in Health and Disease
Transcript
Please wait while the transcript is being prepared...
0:04
Now I want to move on to looking for molecules which are able to
influence these sites and prevent them from making super oxide or hydrogen peroxide.
So, what we've been talking about when we discussed
the capacities of the sites was the assays
using isolated mitochondria where we could run
individual sites and find out how fast they could go.
But of course you can use the same logic to run a screen for
small molecules that might stop individual sites from making superoxide.
Of course, for many sites that's trivial.
For example, we can have Rotenone to block the IQ site.
We can add Myxothiazol,
a very good inhibitor of the IIIQo site.
But of course when we do that,
we also stop ATP production.
We stop electron flow,
we stop oxidative phosphorylation,
we prevent ATP generation.
A therapeutic molecule is very undesirable to
prevent oxidative phosphorylation because that's the main function of the mitochondria.
So, what we're looking for here is molecules which
have a particular property of being able to prevent
superoxide or hydrogen peroxide production from
different sites without preventing oxidative phosphorylation.
So, we run a screen of a small chemical library in-house,
three and a half thousand molecules,
against the superoxide and
hydrogen peroxide production from different sites on isolated muscle mitochondria.
We looked to the IQ site,
IF site, IIIQo site and IIF site.
Those are the four major sites that we think run in vivo.
And also, the glycerol phosphate dehydrogenase site because that was convenient and easy to do.
And then we did the counter screen against mitochondrial membrane potential.
Looking for anything that decreases the mitochondrial potential of the proton motor force is
potentially an inhibitor of electron transport and
that would be discarded from the hits in the screen.
So, the counter screen is oxidative phosphorylation.
The on target screen is the ROS production from particular sites.
And surprisingly, even in this rather small library we found plenty of hits.
The universe is populated by quite a lot of molecules
which are able to specifically prevent ROS production by
the IQ site without preventing
oxidative phosphorylation and without affecting
the ROS production by any other site in the electron transport chain.
And based on that initial screening,
we subsequently screened a much larger library where we found much better compounds,
and I'm going to talk about those in the next slide.
So, these are the complex three suppressors.